Clinically relevant clot resolution via a thromboinflammation-on-a-chip

Clinically relevant clot resolution via a thromboinflammation-on-a-chip

Thromboinflammation occurs in various diseases, leading to life-threatening microvascular occlusion with resulting end-organ failure1–4. Importantly, how microvascular thromboinflammation resolves remains poorly understood due to the small size-scale of microvasculature and the long duration (weeks to months) of this process. Here we introduce a hydrogel-based thromboinflammation-on-a-chip model with long-term culture capabilities to model micro…

VentiV Scientific mechanical thrombectomy system granted FDA approval - Interventional News

VentiV Scientific has announced the US Food and Drug Administration (FDA) clearance of VentiV mechanical thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform. “Electric pump-based thrombectomy systems can unexpectedly clog and/or remove 5–15ml per second of blood before removing blood clots,” said Dan Ryan, board of directors, VentiV Scientific.  “The Pulse is designed to instantly sta…

VentiV Mechanical Thrombectomy System Cleared by FDA - Endovascular Today

April 1, 2025—VentiV Scientific recently announced the FDA clearance of the VentiV mechanical thrombectomy system for removal of blood clots in the peripheral vasculature. According to the company, the system includes the new VentiV Pulse platform. Pulse is designed to instantly start, stop, increase, and/or decrease thrombectomy force at the tip, decrease clogging inside the catheter, and reduce blood loss using any currently available aspirati…